cardiovascular (heart) disease Archive — Page 2 of 10

Vanderbilt Health and Bayer logos on a white background.
January 20, 2026

Bayer and Vanderbilt University Medical Center to advance treatments for cardiovascular and kidney diseases 

The collaboration will leverage VUMC’s resource platform, including its comprehensive datasets hosted in Vanderbilt’s BioVU collection of DNA and plasma to enable data-driven insights and to accelerate discovery and development.

Glowing cyan electrocardiogram waveform with two prominent heartbeat spikes against a dark blue grid background.
January 5, 2026

Vanderbilt Health honored for providing care to patients with congenital heart disease

The program recognizes “the critical role of facilities providing care to patients with congenital heart disease who transition their care from pediatric cardiology to adult cardiology services.”

Participants in blue “Nashville Heart Walk” shirts walk outdoors, with several raising their hands, while other participants in red shirts follow behind.
September 23, 2025

Scenes from the Greater Nashville Heart Walk

The event, which featured more than 50 teams from VUMC, raises awareness and funds for research, advocacy and CPR training to combat heart disease and stroke.

Leigh Anne and Randy Clark pose for a selfie at a soccer stadium, with the field and stands behind them. Beside the photo, text reads: “GAME CHANGER,” “The assist that mattered most:,” and “Saving a life at the stadium.”
June 16, 2025

From stadium to stents, quick response saves soccer fan

When her evening pivoted from cheering for Nashville Soccer Club to suffering a heart attack, well-coordinated teams kept Leigh Anne Clark’s heart and life safe.

Illustration of red blood cells moving through an artery narrowed by cholesterol plaque buildup.
June 4, 2025

VUMC team finds potential target to slow atherosclerosis

The research findings suggest that regulating the immune response to high cholesterol through the protein CaMK4 could enhance blood vessel repair and slow atherosclerosis progression.

Stylized glowing blue heart surrounded by particles, with two open capsules releasing particles above it.
March 12, 2025

Potential therapeutic for Duchenne muscular dystrophy takes step forward

Positive findings from a clinical trial support further study of the investigational drug ifetroban to treat cardiac complications, the leading cause of death in patients with DMD.